We are live on ! Find out more
Morgan Stanley

Morgan Stanley Portfolio holdings

AUM $1.89T Turnover 8.35%
1-Year Est. Return 35.08%
 

Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.

This Fund
S&P 500
This Quarter Est. Return
+4.63%
1 Year Est. Return
+35.08%
3 Year Est. Return
+108.59%
5 Year Est. Return
+118.76%
10 Year Est. Return
+494.78%
AUM
$293B
AUM Growth
+$15.9B
Cap. Flow
+$5.37B
Cap. Flow %
1.83%
Top 10 Hldgs %
13.28%
Holding
6,800
New
189
Increased
3,183
Reduced
2,670
Closed
222
Avg Time Held
2.7 years
Top 10 Avg Time Held
2 years
Top 20 Avg Time Held
2.1 years

Sector Composition

Rank Sector Weight
1 Miscellaneous 30.13%
2 Technology 9.71%
3 Financials 8.96%
4 Healthcare 8.95%
5 Communication Services 7.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
RILY icon
5726
BRC Group Holdings
RILY
$186M
$23K ﹤0.01%
+1,717
New +$17.4K
2016 Q3
0 quarters
SGMA icon
5727
DELISTED
Sigmatron International
SGMA
$23K ﹤0.01%
4,305
– –
2013 Q4
11 quarters
WEAT icon
5728
Teucrium Wheat Fund
WEAT
$274M
$23K ﹤0.01%
+628
New +$23.9K
2016 Q3
0 quarters
XENE icon
5729
Xenon Pharmaceuticals
XENE
$3.28B
$23K ﹤0.01%
2,811
+1,894
+207% +$14.6K
2015 Q4
3 quarters
TBCH icon
5730
Turtle Beach Corp
TBCH
$258M
$23K ﹤0.01%
4,320
-18
-0.4% -$76
2013 Q3
12 quarters
BPTH icon
5731
DELISTED
Bio-Path Holdings Inc
BPTH
$23K ﹤0.01%
+4
New +$25.7K
2016 Q3
0 quarters
FCCY
5732
DELISTED
1st Constitution Bancorp
FCCY
$23K ﹤0.01%
1,693
-1,300
-43% -$16.6K
2013 Q4
11 quarters
SHLDW icon
5733
DELISTED
Sears Holdings Corporation - Warrant
SHLDW
$23K ﹤0.01%
6,765
-17
-0.3% -$70
2014 Q4
7 quarters
CEI icon
5734
DELISTED
Camber Energy, Inc
CEI
– –
0
– –
2013 Q4
11 quarters
ELOS
5735
DELISTED
Syneron Medical Ltd
ELOS
$23K ﹤0.01%
3,202
-1,035
-24% -$7.2K
2013 Q4
11 quarters
CSLS
5736
DELISTED
Credit Suisse X-Links Long/Short Equity ETN's due February 19,2020
CSLS
$23K ﹤0.01%
872
-208
-19% -$5.48K
2015 Q4
3 quarters
CBR
5737
DELISTED
CIBER Inc.
CBR
$23K ﹤0.01%
20,112
+12,153
+153% +$15.7K
2013 Q2
13 quarters
EMAG
5738
DELISTED
VanEck Vectors Emerging Markets Aggregate Bond ETF
EMAG
$23K ﹤0.01%
1,056
+600
+132% +$12.9K
2016 Q2
1 quarter
OBAS
5739
DELISTED
Optibase Ltd
OBAS
$23K ﹤0.01%
2,700
+100
+4% +$773
2014 Q1
10 quarters
JJA
5740
DELISTED
iPath Bloomberg Agriculture Subindex Total Return ETN due October 22, 2037
JJA
$23K ﹤0.01%
656
– –
2015 Q4
3 quarters
RPRX icon
5741
DELISTED
Repros Therapeutics Inc.
RPRX
$23K ﹤0.01%
10,921
-6,341
-37% -$12.5K
2013 Q2
13 quarters
DGP icon
5742
DB Gold Double Long ETN due February 15, 2038
DGP
$224M
$22K ﹤0.01%
+805
New +$22.9K
2016 Q3
0 quarters
MTR icon
5743
Mesa Royalty Trust
MTR
$3.86M
$22K ﹤0.01%
2,600
– –
2013 Q4
11 quarters
RNAC icon
5744
Cartesian Therapeutics
RNAC
$192M
$22K ﹤0.01%
+52
New +$20.3K
2016 Q3
0 quarters
SILJ icon
5745
Amplify Junior Silver Miners ETF
SILJ
$3.21B
$22K ﹤0.01%
1,400
+912
+187% +$15.6K
2016 Q2
1 quarter
STRT icon
5746
STRATTEC Security
STRT
$243M
$22K ﹤0.01%
+636
New +$26.8K
2016 Q3
0 quarters
VIRX icon
5747
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$22K ﹤0.01%
142
-66
-32% -$9.31K
2013 Q2
13 quarters
AMBC.WS icon
5748
DELISTED
Ambac Financial Group
AMBC.WS
$22K ﹤0.01%
+2,502
New +$21K
2016 Q3
0 quarters
GEN icon
5749
DELISTED
Genesis Healthcare, Inc.
GEN
$22K ﹤0.01%
8,390
+7,952
+1,816% +$18.3K
2015 Q1
6 quarters
NXEO
5750
DELISTED
Nexeo Solutions, Inc. Common Stock
NXEO
$22K ﹤0.01%
2,687
-19,362
-88% -$171K
2014 Q3
8 quarters

Similar funds

Morgan Stanley's Q3 2016 Portfolio in Review

As of Q3 2016, Morgan Stanley held 6,800 positions worth $293B, up 5.8% from $277B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Morgan Stanley's Q3 2016 filing shows 189 new, 3,183 increased, 2,670 reduced and 222 closed positions. Its largest new stake was State Street Real Estate Select Sector SPDR ETF: 2,617,803 shares worth $85.8M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $791M.

By sector, the portfolio is most concentrated in Miscellaneous at 30% of assets, up from 30% a quarter earlier, followed by Technology and Financials.

  • Morgan Stanley's largest Q3 2016 buy was State Street Real Estate Select Sector SPDR ETF: 2,617,803 shares worth $85.8M.
  • Morgan Stanley added most to State Street Consumer Staples Select Sector SPDR ETF in Q3 2016, an estimated $623M increase.
  • Morgan Stanley's biggest Q3 2016 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $791M.
  • Morgan Stanley fully exited EMC CORPORATION in Q3 2016, selling an estimated $736M.
  • Morgan Stanley's ten largest holdings make up 13% of its $293B portfolio in Q3 2016.
  • Morgan Stanley opened 189 new positions and closed 222 in Q3 2016.
  • Morgan Stanley's portfolio value rose 5.8% quarter-over-quarter to $293B.

Based on Morgan Stanley's 13F filing for Q3 2016, filed 10 Nov 2016.